Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2003 Setting Biomedical Research Priorities in the 21st Century David B. Resnik, JD, PhD Virtual Mentor. 2003;5(7):276-280. doi: 10.1001/virtualmentor.2003.5.7.msoc1-0307. Viewpoint Jul 2003 Safeguarding the Quality of Clinical Research Joel Lexchin, MD Virtual Mentor. 2003;5(7):283-285. doi: 10.1001/virtualmentor.2003.5.7.oped1-0307. Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308. Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310 Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606. Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. Case and Commentary Sep 2023 According to Which Health Outcomes Measures Should Palliative Psychiatric Prognosis, Progress, and Success Be Defined? Nicolas Trad This commentary on a case considers moral reasons to adopt a palliative approach to the care of some psychiatric patients. AMA J Ethics. 2023;25(9):E684-689. doi: 10.1001/amajethics.2023.684. Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Medicine and Society Jul 2003 Setting Biomedical Research Priorities in the 21st Century David B. Resnik, JD, PhD Virtual Mentor. 2003;5(7):276-280. doi: 10.1001/virtualmentor.2003.5.7.msoc1-0307.
Viewpoint Jul 2003 Safeguarding the Quality of Clinical Research Joel Lexchin, MD Virtual Mentor. 2003;5(7):283-285. doi: 10.1001/virtualmentor.2003.5.7.oped1-0307.
Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308.
Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310
Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606.
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
Case and Commentary Sep 2023 According to Which Health Outcomes Measures Should Palliative Psychiatric Prognosis, Progress, and Success Be Defined? Nicolas Trad This commentary on a case considers moral reasons to adopt a palliative approach to the care of some psychiatric patients. AMA J Ethics. 2023;25(9):E684-689. doi: 10.1001/amajethics.2023.684.
Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.